MBD-seq as a cost-effective approach for methylome-wide association studies: Demonstration in 1500 case-control samples

Epigenomics

Volumn 4, Issue 6, 2012, Pages 605-621

  Aberg, Karolina A ^a   McClay, Joseph L ^a   Nerella, Srilaxmi ^a   Xie, Lin Y ^a   Clark, Shaunna L ^a   Hudson, Alexandra D ^a   Bukszár, Jozsef ^a   Adkins, Daniel ^a   Consortium, Swedish Schizophrenia ^d   Hultman, Christina M ^b   Sullivan, Patrick F ^c   Magnusson, Patrik Ke ^b   Van Den Oord, Edwin J C G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

MBD; methylome wide association studies; next generation sequencing; principal component analysis; pyrosequencing

Indexed keywords

DNA; METHYL CPG BINDING PROTEIN;

ANALYTICAL EQUIPMENT; ARTICLE; CASE CONTROL STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA PROCESSING; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; METHODOLOGY; METHYLOME WIDE ASSOCIATION STUDY; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PYROSEQUENCING; QUALITY CONTROL; SCHIZOPHRENIA; SCREENING TEST;

CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; GENETIC ASSOCIATION STUDIES; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; RECEPTORS, AMPA; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA;

EID: 84871404318     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.12.59     Document Type: Article

References (74)

1. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11, 191-203 (2010).
2. Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science 330, 612-616 (2010).
3. Coulondre C, Miller JH, Farabaugh PJ, Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature 274, 775-780 (1978). (Pubitemid 8406156)
4. Kwok JB. Role of epigenetics in Alzheimer's and Parkinson's disease. Epigenomics 2, 671-682 (2010).
5. Hedrich CM, Tsokos GC. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol. Med. 17, 714-724 (2011).
6. Ordovas JM, Smith CE. Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 7, 510-519 (2010).
7. Sarkies P, Sale JE. Cellular epigenetic stability and cancer. Trends Genet. 28, 118-127 (2012).
8. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433-440 (2007). (Pubitemid 46816750)
9. Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology -analysis of host and tumor factors for personalized medicine. Nat. Rev. Clin. Oncol. 8, 711-719 (2011).
10. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465, 721-727 (2010).
11. Jost JP, Saluz HP, Pawlak A. Estradiol down regulates the binding activity of an avian vitellogenin gene repressor (MDBP 2) and triggers a gradual demethylation of the mCpG pair of its DNA binding site. Nucleic Acids Res. 19, 5771-5775 (1991). (Pubitemid 21912987)
12. Yokomori N, Moore R, Negishi M. Sexually dimorphic DNA demethylation in the promoter of the Slp (sex-limited protein) gene in mouse liver. Proc. Natl Acad. Sci. USA 92, 1302-1306 (1995).
13. Sutherland JE, Costa M. Epigenetics and the environment. Ann. NY Acad. Sci. 983, 151-160 (2003). (Pubitemid 36399328)
14. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20, 63-68 (2004). (Pubitemid 38091581)
15. Cooney CA. Are somatic cells inherently deficient in methylation metabolism? A proposed mechanism for DNA methylation loss, senescence and aging. Growth. Dev. Aging 57, 261-273 (1993). (Pubitemid 23363343)
16. Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24, 88-91 (2000). (Pubitemid 30041428)
17. Laird PW. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3, 253-266 (2003). (Pubitemid 37328861)
18. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529-541 (2011).
19. Bibikova M, Le J, Barnes B et al. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 1, 177-200 (2009).
20. Li Y, Zhu J, Tian G et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol. 8, e1000533 (2010).
21. Frommer M, McDonald LE, Millar DS et al. A genomic sequencing protocol that yields a positive display of 5 methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827-1831 (1992).
22. Lister R, Ecker Jr. Finding the fifth base: genome-wide sequencing of cytosine methylation. Genome Res. 19, 959-966 (2009).
23. Harris RA, Wang T, Coarfa C et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 28, 1097-1105 (2010).
24. Irizarry RA, Ladd-Acosta C, Wen B et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009).
25. Aberg K, Khachane AN, Rudolf G et al. Methylome-wide comparison of human genomic DNA extracted from whole blood and from EBV-transformed lymphocyte cell lines. Eur. J. Hum. Genet. 20(9), 953-955 (2012).
26. Serre D, Lee BH, Ting AH. MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res. 38, 391-399 (2010).
27. Suzuki M, Greally JM. DNA methylation profiling using HpaII tiny fragment enrichment by ligation-mediated PCR (HELP). Methods 52, 218-222 (2010).
28. Mohn F, Weber M, Schubeler D, Roloff TC. Methylated DNA immunoprecipitation (MeDIP). Methods Mol. Biol. 507, 55-64 (2009).
29. Nair SS, Coolen MW, Stirzaker C et al. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 6, 34-44 (2011).
30. Bock C, Tomazou EM, Brinkman AB et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat. Biotechnol. 28, 1106-1114 (2010).
31. Hogart A, Lichtenberg J, Ajay SS, Anderson SM, Margulies EH, Bodine DM. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal over-representation of ETS transcription factor binding sites. Genome Res. 22(8), 1407-1418 (2012).
32. Lan X, Adams C, Landers M et al. High resolution detection and analysis of CpG dinucleotides methylation using MBD-Seq technology. PLoS One 6, e22226 (2011).
33. Bergen SE, O'Dushlaine CT, Ripke S et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared to bipolar disorder. Mol. Psychiatry 17(9), 880-886 (2012).
34. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study of schizophrenia identifies five novel loci. Nat. Genet. 43, 969-976 (2011).
35. International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
36. McKernan KJ, Peckham HE, Costa GL et al. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res. 19(9), 1527-1541 (2009).
37. Pepke S, Wold B, Mortazavi A. Computation for ChIP-seq and RNA-seq studies. Nat. Methods. 6(11 Suppl.), S22-S32 (2009).
38. Zhang Y, Liu T, Meyer CA et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9(9), R137 (2008).
39. Down TA, Rakyan VK, Turner DJ et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol. 26(7), 779-785 (2008). (Pubitemid 351961453)
40. Chavez L, Jozefczuk J, Grimm C et al. Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res. 20(10), 1441-1450 (2010).
41. Ji Y, Xu Y, Zhang Q et al. BM-Map: Bayesian mapping of multireads for next-generation sequencing data. Biometrics 67(4), 1215-1224 (2011).
42. Bollen KA. Structural Equations With Latent Variables. Wiley, NY, USA (1989).
43. Bock C, Walter J, Paulsen M, Lengauer T. Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res. 36(10), e55 (2008).
44. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81(3), 559-575 (2007). (Pubitemid 47330214)
45. Alter O, Brown PO, Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc. Natl Acad. Sci. USA 97(18), 10101-10106 (2000).
46. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 38(8), 904-909 (2006). (Pubitemid 44141658)
47. Gower JC. Some distance properties of latent root and vector methods used in multivariate analysis. Biometrika 53, 325-338 (1966).
48. Pelizzola M, Koga Y, Urban AE et al. MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res. 18(10), 1652-1659 (2008).
49. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Erlbaum, NJ, USA (1988).
50. Beleford D, Liu Z, Rattan R et al. Methylation induced gene silencing of HtrA3 in smoking-related lung cancer. Clin. Cancer Res. 16(2), 398-409 (2010).
51. Lohr JB, Flynn K. Smoking and schizophrenia. Schizophr Res. 8(2), 93-102 (1992).
52. Kristiansson K, Perola M, Tikkanen E et al. Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ. Cardiovasc. Genet. 5(2), 242-249 (2012).
53. Gonzalo S. Epigenetic alterations in aging. J. Appl. Physiol. 109(2), 586-597 (2010).
54. Koch CM, Wagner W. Epigenetic-aging-signature to determine age in different tissues. Aging (Albany NY). 3(10), 1018-1027 (2011).
55. Bocklandt S, Lin W, Sehl ME et al. Epigenetic predictor of age. PLoS One 6(6), e14821 (2011).
56. Bell JT, Tsai PC, Yang TP et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 8(4), e1002629 (2012).
57. Ushida H, Kawakami T, Minami K et al. Methylation profile of DNA repetitive elements in human testicular germ cell tumor. Mol Carcinog. 51(9), 711-722 (2011).
58. Bollati V, Galimberti D, Pergoli L et al. DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun. 25(6), 1078-1083 (2011).
59. Bollati V, Fabris S, Pegoraro V et al. Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Carcinogenesis. 30(8), 1330-1335 (2009).
60. Cohen J. The cost of dichotomization. Applied Psychological Measurement 7, 249-253 (1983).
61. Christensen BC, Houseman EA, Marsit CJ et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 5(8), e1000602 (2009).
62. Eckhardt F, Lewin J, Cortese R et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet. 38(12), 1378-1385 (2006). (Pubitemid 44837559)
63. Monk M, Boubelik M, Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99(3), 371-382 (1987). (Pubitemid 17048855)
64. Efstratiadis A. Parental imprinting of autosomal mammalian genes. Curr. Opin. Genet. Dev. 4(2), 265-280 (1994). (Pubitemid 24114859)
65. Yeivin A, Razin A. Gene methylation patterns and expression. EXS 64, 523-568 (1993).
66. Rakyan VK, Preis J, Morgan HD, Whitelaw E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem J. 356(Pt 1), 1-10 (2001). (Pubitemid 34275701)
67. Lavon I, Refael M, Zelikovitch B, Shalom E, Siegal T. Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. Neuro Oncol. 12(2), 173-180 (2010).
68. McGowan PO, Meaney MJ, Szyf M. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res. 1237, 12-24 (2008).
69. Pilsner JR, Liu X, Ahsan H et al. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am. J. Clin. Nutr. 86(4), 1179-1186 (2007). (Pubitemid 47538325)
70. Sutherland JE, Costa M. Epigenetics and the environment. Ann. NY Acad. Sci. 983, 151-160 (2003). (Pubitemid 36399328)
71. Kerkel K, Spadola A, Yuan E et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet. 40(7), 904-908 (2008).
72. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The SVA package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28(6), 882-883 (2012).
73. Center for Biomarker Research and Personalized Medicine. www.biomarker.vcu.edu
74. UCSC Genome Bioinformatics. http://genome.ucsc.edu